SCHEMBL20076239

SCHEMBL20076239

CN1CC(CN2CCN(C(=O)OC(C)(C)C)CC2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.47
CNR1 P21554 1/20 0.46
USP2 O75604 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
HPGD P15428 1/20 0.42
EPHX2 P34913 1/20 0.42
TERT O14746 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.40
RECQL P46063 1/20 0.40
EPHX1 P07099 1/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27432720 0.87 CACNA2D1 (0.48) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL20873836 0.86 CNR1 (0.51) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL1100404 0.86 CNR1 (0.51) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL27308696 0.85 CACNA2D1 (0.47) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL19853552 0.85 CNR1 (0.41) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL20873854 0.84 HPGD (0.51) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL25338213 0.84 NR1H2 (0.49) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL6152170 0.84 HPGD (0.48) NR1H2CNR1USP2SMN1; SMN2HPGD
SCHEMBL2732005 0.83 HPGD (0.50) NR1H2CNR1USP2SMN1; SMN2CHRM2
SCHEMBL1307642 0.83 EPHX1 (0.51) NR1H2CNR1USP2SMN1; SMN2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3660004-B1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR ARVINAS OPERATIONS INC (US) 2023-02-22 EP disclosed
WO-2018071606-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas, Inc. (US) 2018-04-19 WO disclosed